Role of Masseter Muscle β₂-Adrenergic Signaling in Regulation of Muscle Activity, Myosin Heavy Chain Transition, and Hypertrophy
-
- Ohnuki Yoshiki
- Department of Physiology, Tsurumi University School of Dental Medicine, Japan
-
- Umeki Daisuke
- Department of Orthodontics, Tsurumi University School of Dental Medicine, Japan
-
- Cai Wenqian
- Cardiovascular Research Institute, Yokohama City University Graduate School of Medicine, Japan
-
- Kawai Nobuhiko
- Department of Orthodontics and Dentofacial Orthopedics, Institute of Health Biosciences, The University of Tokushima Graduate School of Oral Sciences, Japan
-
- Mototani Yasumasa
- Department of Physiology, Tsurumi University School of Dental Medicine, Japan
-
- Shiozawa Kouichi
- Department of Physiology, Tsurumi University School of Dental Medicine, Japan
-
- Jin Hui-Ling
- Cardiovascular Research Institute, Yokohama City University Graduate School of Medicine, Japan
-
- Fujita Takayuki
- Cardiovascular Research Institute, Yokohama City University Graduate School of Medicine, Japan
-
- Tanaka Eiji
- Department of Orthodontics and Dentofacial Orthopedics, Institute of Health Biosciences, The University of Tokushima Graduate School of Oral Sciences, Japan
-
- Saeki Yasutake
- Department of Physiology, Tsurumi University School of Dental Medicine, Japan
-
- Okumura Satoshi
- Department of Physiology, Tsurumi University School of Dental Medicine, Japan Cardiovascular Research Institute, Yokohama City University Graduate School of Medicine, Japan
書誌事項
- タイトル別名
-
- Role of Masseter Muscle <i>β</i><sub>2</sub>-Adrenergic Signaling in Regulation of Muscle Activity, Myosin Heavy Chain Transition, and Hypertrophy
この論文をさがす
説明
Chronic administration of clenbuterol (CB), a lipophilic β2-adrenoceptor (β2-AR) agonist, induces skeletal muscle hypertrophy and slow-to-fast fiber–type transitions in mammalian species, but the mechanism and pathophysiological roles of these changes have not been explored. Here, we examined the effects of CB not only on masseter muscle mass, fiber diameter, and myosin heavy chain (MHC) composition, but also on daily muscle activity, a factor influencing muscle phenotype, by means of electromyogram analysis in rats. MHC transition towards faster isoforms was induced by 2-week CB treatment. In addition, daily duty time was increased at 1 day, 1 week, and 2 weeks after the start of CB treatment and its increase was greater at high activity level (6-fold) than at low activity level (2-fold). In order to examine whether these effects of CB were mediated through muscle or CNS β2-AR stimulation, we compared these effects of CB with those of salbutamol (SB), a hydrophilic β2-AR agonist. SB treatment induced masseter hypertrophy and MHC transition, like CB, but did not increase daily activity. These results suggest that CB-mediated slow-to-fast MHC transition with hypertrophy was induced through direct muscle β2-AR stimulation, but the increase of daily duty time was mediated through the CNS.<br>[Supplementary Figures: available only at http://dx.doi.org/10.1254/jphs.12271FP]
収録刊行物
-
- Journal of Pharmacological Sciences
-
Journal of Pharmacological Sciences 123 (1), 36-46, 2013
公益社団法人 日本薬理学会
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1390001205180511104
-
- NII論文ID
- 10031202961
-
- NII書誌ID
- AA11806667
-
- COI
- 1:CAS:528:DC%2BC3sXhsF2ktrzM
-
- ISSN
- 13478648
- 13478613
-
- NDL書誌ID
- 024863691
-
- PubMed
- 23985574
-
- 本文言語コード
- en
-
- 資料種別
- journal article
-
- データソース種別
-
- JaLC
- NDLサーチ
- Crossref
- PubMed
- CiNii Articles
- OpenAIRE
-
- 抄録ライセンスフラグ
- 使用不可